GUTS · Fractyl Health, Inc.
Market Cap
$113.29M
Shares
159.18M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$0
-100%
FY2025
Net Income
-$140.95M
-105.2%
FY2025
Gross Margin
46.24%
+10.4pp
FY2024
Operating Margin
-100570.97%
-58207.6pp
FY2024
Diluted EPS
-$1.86
-14.8%
FY2025
Operating Cash Flow
-$90.33M
-37.9%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| — | $0 | $93K | $120K | |
| — | $0 | $50K | $77K | |
| — | — | $43K | $43K | |
| — | — | 46.24% | 35.83% | |
| $63.36M | $74.54M | $70.47M | $38.04M | |
| $22.53M | $22.28M | $23.1M | $12.84M | |
| $85.89M | $96.82M | $93.57M | $50.88M | |
| -$85.89M | -$96.82M | -$93.53M | -$50.84M | |
| — | — | -100570.97% | -42363.33% | |
| $1.84M | $1.54M | $4.15M | $1.26M | |
| -$19.76M | -$44.14M | $24.84M | -$26.26M | |
| — | $0 | $0 | $0 | |
| -$105.65M | -$140.95M | -$68.69M | -$77.09M | |
| — | — | -73864.52% | -64242.5% | |
| — | -$140.95M | -$70.43M | -$94.27M | |
| USD/shares | -$0.90 | -$1.86 | -$1.62 | -$45.29 |
| USD/shares | -$0.90 | -$1.86 | -$1.62 | -$45.29 |
| shares | — | 75.82M | 43.54M | 2.08M |
| shares | — | 75.82M | 43.54M | 2.08M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 4.76×
EV/EBIT
—
Peer median 9.78×
P/E (TTM)
—
Peer median 9.58×
Peer medians compare against the 295 similar-size Biotechnology companies (of 514 listed).
Key facts
CIK
1572616
CUSIP
35168W103
13F (30d)
62 filings
62 filers
Visit website
Investor relations